Charles Antzelevitch
Charles Antzelevitch is a prominent figure in the field of cardiac electrophysiology, known for his extensive research on the mechanisms underlying cardiac arrhythmias. His work has significantly contributed to the understanding of Brugada syndrome and other channelopathies.
Early Life and Education[edit]
Charles Antzelevitch was born in the United States. He pursued his undergraduate studies in biology and went on to earn a Ph.D. in pharmacology from a prestigious university. His early interest in the electrical activity of the heart led him to specialize in cardiac electrophysiology.
Career[edit]
Antzelevitch began his career as a researcher focusing on the electrical properties of the heart. He has held various academic and research positions, contributing to the field through both teaching and groundbreaking research.
Research Contributions[edit]
Antzelevitch is best known for his work on the ionic mechanisms of cardiac arrhythmias. His research has provided insights into the role of ion channels in the development of arrhythmias, particularly in conditions like Brugada syndrome. He has published numerous articles in leading scientific journals and has been a frequent speaker at international conferences.
Brugada Syndrome[edit]
One of Antzelevitch's most significant contributions is his research on Brugada syndrome, a genetic disorder that can lead to sudden cardiac death. His studies have helped to elucidate the genetic and molecular basis of the syndrome, leading to improved diagnostic and therapeutic strategies.
Awards and Honors[edit]
Throughout his career, Antzelevitch has received numerous awards for his contributions to medical science. He is a fellow of several prestigious societies and has been recognized for his work in advancing the understanding of cardiac electrophysiology.
Personal Life[edit]
Charles Antzelevitch is known for his dedication to science and education. Outside of his professional life, he enjoys spending time with his family and engaging in various hobbies.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian